Administration of human immune globulin product

Administration of human immune globulin product (procedure)

procedure
£1.00

Supplier: international · SCTID 117103007

Also known as (2)
  • Administration of immune globulin product of human origin
  • Administration of immune serum globulin, human

Found in

Passive immunisation

Related products

Adalimumab therapy
£1.00
Administration of antitoxin
£1.00
Administration of bebtelovimab
£1.00
Administration of casirivimab
£1.00
Administration of human anti-D immunoglobulin
£1.00
Administration of imdevimab
£1.00
Administration of immune serum
£1.00
Administration of immunoglobulin by intravenous route
£1.00
Administration of sarilumab
£1.00
Administration of sotrovimab
£1.00
Administration of tocilizumab
£1.00
Anifrolumab therapy
£1.00
Belantamab mafodotin therapy
£1.00
Belimumab therapy
£1.00
Canakinumab therapy
£1.00
Certolizumab pegol therapy
£1.00
Continuous infusion of immunoglobulin
£1.00
Denosumab therapy
£1.00
Golimumab therapy
£1.00
Guselkumab therapy
£1.00
Infliximab therapy
£1.00
Injection of indium 111 and ibritumomab tiuxetan
£1.00
Injection of normal human immunoglobulin
£1.00
Intramuscular immunotherapy
£1.00
Basket
Total£0.00